Hemorrane plus + Hemorrane + Placebo
Phase 3Terminated 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Haemorrhoids Without Complication
Conditions
Haemorrhoids Without Complication
Trial Timeline
Mar 30, 2023 → Jan 4, 2024
NCT ID
NCT05788497About Hemorrane plus + Hemorrane + Placebo
Hemorrane plus + Hemorrane + Placebo is a phase 3 stage product being developed by Faes Farma for Haemorrhoids Without Complication. The current trial status is terminated. This product is registered under clinical trial identifier NCT05788497. Target conditions include Haemorrhoids Without Complication.
Hype Score Breakdown
Clinical
17
Activity
0
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05788497 | Phase 3 | Terminated |